Opus Genetics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $17.1M | $11.6M |
| FY2017 | — | $16.8M | $8.9M |
| FY2018 | — | $-1.7M | $8.7M |
| FY2019 | — | $-7.6M | $1.5M |
| FY2020 | — | $-13.5M | $16.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $17.1M | $11.6M |
| FY2017 | — | $16.8M | $8.9M |
| FY2018 | — | $-1.7M | $8.7M |
| FY2019 | — | $-7.6M | $1.5M |
| FY2020 | — | $-13.5M | $16.4M |